Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/76718
Share/Export:
logo share SHARE logo core CORE BASE
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE
Title

Dendritic MRI contrast agents: An efficient prelabeling approach based on CuAAC

AuthorsFernández-Trillo, Francisco; Pacheco-Torres, Jesús ; Correa, Juan; Ballesteros, Paloma ORCID; López-Larrubia, Pilar CSIC ORCID; Cerdán, Sebastián CSIC ORCID; Riguera, Ricardo; Fernandez-Megia, Eduardo
Issue Date2011
PublisherAmerican Chemical Society
CitationBiomacromolecules 12(8): 2902-2907 (2011)
AbstractThe Cu(I)-catalyzed azide-alkyne cycloaddition (CuAAC) allows the efficient and complete functionalization of dendrimers with preformed Gd chelates (prelabeling) to give monodisperse macromolecular contrast agents (CAs) for magnetic resonance imaging (MRI). This monodispersity contrasts with the typical distribution of materials obtained by classical routes and facilitates the characterization and quality control demanded for clinical applications. The potential of a new family of PEG-dendritic CA based on a gallic acid-triethylene glycol (GATG) core functionalized with up to 27 Gd complexes has been explored in vitro and in vivo, showing contrast enhancements similar to those of Gadomer-17, which reveals them to be a promising platform for the development of CA for MRI. © 2011 American Chemical Society.
URIhttp://hdl.handle.net/10261/76718
DOI10.1021/bm2004466
Identifiersdoi: 10.1021/bm2004466
issn: 1525-7797
e-issn: 1526-4602
Appears in Collections:(IIBM) Artículos

Files in This Item:
File Description SizeFormat
accesoRestringido.pdf15,38 kBAdobe PDFThumbnail
View/Open
Show full item record
Review this work

SCOPUSTM   
Citations

35
checked on May 14, 2022

WEB OF SCIENCETM
Citations

35
checked on May 13, 2022

Page view(s)

323
checked on May 15, 2022

Download(s)

98
checked on May 15, 2022

Google ScholarTM

Check

Altmetric

Dimensions


WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.